MRM Wins Novartis Aclasta European CRM Business

Share this article:
Novartis tapped MRM Worldwide, an interactive and relationship marketing company, to undertake European patient communications for its Aclasta CRM program, it was announced yesterday.


Aclasta is an annual infusion for the treatment of Paget's disease and is in the third phase of clinical trials for other metabolic bone disorders such as osteoporosis.


Novartis said it also is considering letting MRM Worldwide pitch for all of its global CRM opportunities.


MRM Partners, a unit of McCann Worldgroup, which is owned by Interpublic Group of Companies, has 62 offices in 37 countries, more than 1,700 employees and clients such as Coca-Cola, Dell, General Motors, Intel, Royal Bank of Scotland Group, Tesco, UPS, Unilever and Vodafone.


Share this article:
You must be a registered member of Direct Marketing News to post a comment.
close

Next Article in Data/Analytics

Sign up to our newsletters

Follow us on Twitter @dmnews

Latest Jobs:

Featured Listings

More in Data/Analytics

Acxiom East?

Acxiom East?

Ogilvy & Mather launches OgilvyAmp, a think tank for data-driven marketers headed by expatriates from Little Rock's best-known data company.

Epicor to Acquire Analytics Provider QuantiSense

Epicor to Acquire Analytics Provider QuantiSense

Retail solutions provider seeks to up its data analytics game for large and midsized retailers.

One Third of Companies Fail to Measure Data Quality ROI

One Third of Companies Fail to Measure Data ...

Twenty percent of companies assume their data quality tools pay off, while another 10% doesn't monitor ROI at all.